Patents by Inventor Jean-Pierre Delatinne

Jean-Pierre Delatinne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline forms of seletalisib
    Patent number: 11059820
    Abstract: Crystalline forms of seletalisib, designated as Form B and Form F and characterized herein, being selective inhibitors of PI3 kinase enzymes, in particular of the human PBK? isoform, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.
    Type: Grant
    Filed: May 24, 2018
    Date of Patent: July 13, 2021
    Assignee: UCB Biopharma SPRL
    Inventors: Luc Lambert Jozef Jan Aerts, Georges Assaf, Nicolas Edmond Carly, Vincent Adolphe Carol Cool, Jean-Pierre Delatinne, Laurent Jacques Willy Delhaye, Jean Paul Kestemont, Sarah Le Meur
  • CRYSTALLINE FORMS OF SELETALISIB
    Publication number: 20200095246
    Abstract: Crystalline forms of seletalisib, designated as Form B and Form F and characterized herein, being selective inhibitors of PI3 kinase enzymes, in particular of the human PBK? isoform, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.
    Type: Application
    Filed: May 24, 2018
    Publication date: March 26, 2020
    Inventors: Luc Lambert Jozef Jan AERTS, Georges ASSAF, Nicolas Edmond CARLY, Vincent Adolphe Carol COOL, Jean-Pierre DELATINNE, Laurent Jacques Willy DELHAYE, Jean Paul KESTEMONT, Sarah LE MEUR,
  • Process for the preparation of nitrogen substituted aminotetralins derivatives
    Patent number: 8981121
    Abstract: The present invention provides an alternative synthesis of N-substituted aminotetralines comprising resolution of N-substituted aminotetralins of formula (II), wherein R1, R2 and R3 are as defined for compound of formula (I).
    Type: Grant
    Filed: June 24, 2011
    Date of Patent: March 17, 2015
    Assignee: UCB Pharma GmbH
    Inventors: Celal Ates, Arnaud Schule, Magali Palacio, Paul Deutsch, David Vasselin, Nicolas Carly, Ganesh Phadtare, Swapnil Yerande, Jean-Pierre Delatinne, Maria Luisa Escudero Hernandez, Veronique Pinilla
  • Novel Process for the Preparation of Nitrogen Substituted Aminotetralins Derivatives
    Publication number: 20130102794
    Abstract: The present invention provides an alternative synthesis of N-substituted aminotetralines comprising resolution of N-substituted aminotetralins of formula (II), wherein R1, R2 and R3 are as defined for compound of formula (I).
    Type: Application
    Filed: June 24, 2011
    Publication date: April 25, 2013
    Applicant: UCB PHARMA GMBH
    Inventors: Celal Ates, Arnaud Schule, Magali Palacio, Paul Deutsch, David Vasselin, Nicolas Carly, Ganesh Phadtare, Swapnil Yerande, Jean-Pierre Delatinne, Maria Luisa Escudero Hernandez, Veronique Pinilla